| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | KK-LC-1 Blocking Peptide is synthetically produced from the 20-70 and 61-111 sequence and is suitable for use in western blot applications. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: | CT83 |
| Gene ID: | 203413 |
| Uniprot ID: | KKLC1_HUMAN |
| Immunogen Region: | 20-70 and 61-111 |
| Immunogen: | Synthetic peptide taken within amino acid region 20-70 and 61-111 on human Kita-kyushu lung cancer antigen 1. |
| Peptide Name | Kita-Kyushu Lung Cancer Antigen 1Kk-Lc-1Cancer/Testis Antigen 83 |
| Cellular Localisation | Cell MembraneSingle-Pass Type Ii Membrane Protein |
| Alternative Peptide Names | Kita-Kyushu Lung Cancer Antigen 1 proteinKk-Lc-1 proteinCancer/Testis Antigen 83 proteinCT83 proteinCXorf61 proteinKKLC1 protein |
Information sourced from Uniprot.org